Naoum, Emily E.
Dalia, Adam A.
Roberts, Russel J.
Devine, Lauren T.
Ortoleva, Jamel http://orcid.org/0000-0001-6751-7213
Article History
Received: 2 March 2022
Accepted: 20 June 2022
First Online: 27 June 2022
Declarations
:
: This study was approved by the institutional review board (Protocol #2020P000892), at Massachusetts General Hospital (Boston, MA, USA).
: Not applicable
: Dr. Ortoleva has received a one time honoraria from La Jolla Pharmaceutical for participating in a one time expert advisory panel on the use of angiotensin II in cardiovascular surgery patients. There are no other declarations of interest.